Melanoma proteomics unravels major differences related to mutational status
Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Mariana Díaz-Almirón, Claudia Fortes, Rocío López-Vacas, Iván Márquez-Rodas, Ainara Soria, Juan Ángel Fresno Vara, Enrique Espinosa
The paper uses proteomics and computational methods to identify molecular differences between BRAF-mutated and BRAF non-mutated melanoma tumors.
bioRxiv · Oct 6, 2017 · PreprintCancer Biology